Bioscience Valuation at the INCATE Workshop on P. aeruginosa Innovation

In early March, Bioscience Valuation participated in the INCATE workshop on the development of new Pseudomonas aeruginosa interventions in Basel.

Our colleague Diana Stukalkina, MD, Healthcare Analyst, presented at the workshop, contributing to discussions alongside leading experts from academia, biotech, and regulatory fields. The event focused on key scientific challenges, development pathways, and collaboration opportunities in addressing this critical antimicrobial resistance (AMR) pathogen.

We thank INCATE for the excellent organization, as well as ETH Department of Biosystems Science and Engineering (D-BSSE), NCCR AntiResist, and the German Center for Infection Research (DZIF) for their support.

Finally, thank you to all participants for the engaging discussions and shared commitment to advancing solutions against AMR.